Phase III Study: Tiotropium Effective In Symptomatic Asthma Patients – Science 2.0 – Science 2.0

Phase III Study: Tiotropium Effective In Symptomatic Asthma Patients – Science 2.0
Science 2.0
Tiotropium delivered by the Respimat(R) Soft Mist(TM) Inhaler (SMI) increases time to first severe exacerbation and first episode of asthma worsening across a broad spectrum of patients who remain symptomatic despite at least inhaled corticosteroids …
Phase III results: tiotropium(*) Respimat(R) effective in symptomatic asthma …Wall Street Journal (press release)
Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a …PR Newswire (press release)

all 4 news articles »